Syenex Overview

  • Year Founded
  • 2022

Year Founded

  • Status
  • Private

  • Employees
  • 8

Employees

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $8.66M

  • Investors
  • 8

Syenex General Information

Description

Developer of bioengineering technologies designed to improve the precision and effectiveness of therapeutic cell engineering. The company offers optimized enveloped vector surface compositions, programmable payload-compatible delivery systems, scalable manufacturing integrations, and regulatory support services, enabling drug developers and biotechnology researchers to create advanced medicines with greater efficiency and reliability.

Contact Information

Website
www.syenex.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 1801 Maple Avenue
  • Suite 6210
  • Evanston, IL 60201
  • United States
+1 (914)
Primary Industry
Discovery Tools (Healthcare)
Vertical(s)
Life Sciences
Corporate Office
  • 1801 Maple Avenue
  • Suite 6210
  • Evanston, IL 60201
  • United States
+1 (914)

Syenex Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Syenex Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Seed Round 24-Jan-2025 $8.66M Completed Generating Revenue
4. Accelerator/Incubator 29-May-2024 Completed Generating Revenue
3. Accelerator/Incubator 01-Jan-2023 Completed Generating Revenue
2. Seed Round 07-Sep-2022 $5M $5M Completed Generating Revenue
1. University Spin-Out 01-Jan-2022 Completed Generating Revenue
To view Syenex’s complete valuation and funding history, request access »

Syenex Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Seed
Seed-2
Seed-1 2,565,411 $0.000010 8% $0.19 $0.19 1x $0.19 3.66%
To view Syenex’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Syenex Patents

  • 5

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 3

    Pending

  • Expiring in next 12 mo

Syenex Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026102035-A1 Engineered cell-derived lipid bilayer particles and uses thereof Pending 05-Nov-2024
WO-2025106726-A1 Engineered lipid bilayer particles displaying sirpa Inactive 15-Nov-2023
AU-2023269680-A1 Receptor engagement-mediated enhancement of biologics delivery Pending 13-May-2022
EP-4522224-A1 Receptor engagement-mediated enhancement of biologics delivery Pending 13-May-2022
WO-2023220457-A1 Receptor engagement-mediated enhancement of biologics delivery Inactive 13-May-2022 A61K47/6901
To view Syenex’s complete patent history, request access »

Syenex Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Syenex Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds
Lightbank (Venture Capital) Venture Capital Minority
MedTech Innovator Accelerator/Incubator
The Querrey InQbation Lab Accelerator/Incubator
AlleyCorp Venture Capital Minority
KdT Ventures Venture Capital Minority
You’re viewing 5 of 8 investors. Get the full list »

Ready to get started?

Request a free trial

Syenex FAQs

  • When was Syenex founded?

    Syenex was founded in 2022.

  • Where is Syenex headquartered?

    Syenex is headquartered in Evanston, IL.

  • What is the size of Syenex?

    Syenex has 8 total employees.

  • What industry is Syenex in?

    Syenex’s primary industry is Discovery Tools (Healthcare).

  • Is Syenex a private or public company?

    Syenex is a Private company.

  • What is the current valuation of Syenex?

    The current valuation of Syenex is .

  • What is Syenex’s current revenue?

    The current revenue for Syenex is .

  • How much funding has Syenex raised over time?

    Syenex has raised $13.7M.

  • Who are Syenex’s investors?

    Lightbank (Venture Capital), MedTech Innovator, The Querrey InQbation Lab, AlleyCorp, and KdT Ventures are 5 of 8 investors who have invested in Syenex.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process